174 related articles for article (PubMed ID: 21828236)
1. Circulating markers of interstitial lung disease and subsequent risk of lung cancer.
Shiels MS; Chaturvedi AK; Katki HA; Gochuico BR; Caporaso NE; Engels EA
Cancer Epidemiol Biomarkers Prev; 2011 Oct; 20(10):2262-72. PubMed ID: 21828236
[TBL] [Abstract][Full Text] [Related]
2. Circulating markers of cellular immune activation in prediagnostic blood sample and lung cancer risk in the Lung Cancer Cohort Consortium (LC3).
Huang JY; Larose TL; Luu HN; Wang R; Fanidi A; Alcala K; Stevens VL; Weinstein SJ; Albanes D; Caporaso NE; Purdue MP; Ziegler RG; Freedman ND; Lan Q; Prentice RL; Pettinger M; Thomson CA; Cai Q; Wu J; Blot WJ; Shu XO; Zheng W; Arslan AA; Zeleniuch-Jacquotte A; Le Marchand L; Wilkens LR; Haiman CA; Zhang X; Stampfer MJ; Han J; Giles GG; Hodge AM; Severi G; Johansson M; Grankvist K; Langhammer A; Hveem K; Xiang YB; Li HL; Gao YT; Visvanathan K; Ueland PM; Midttun Ø; Ulvi A; Buring JE; Lee IM; Sesso HD; Gaziano JM; Manjer J; Relton C; Koh WP; Brennan P; Johansson M; Yuan JM
Int J Cancer; 2020 May; 146(9):2394-2405. PubMed ID: 31276202
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of the Diagnostic Efficacies of Serological Markers KL-6, SP-A, SP-D, CCL2, and CXCL13 in Idiopathic Interstitial Pneumonia.
Xue M; Guo Z; Cai C; Sun B; Wang H
Respiration; 2019; 98(6):534-545. PubMed ID: 31665737
[TBL] [Abstract][Full Text] [Related]
4. Serum KL-6 levels in lung cancer patients with or without interstitial lung disease.
Miyazaki K; Kurishima K; Kagohashi K; Kawaguchi M; Ishikawa H; Satoh H; Hizawa N
J Clin Lab Anal; 2010; 24(5):295-9. PubMed ID: 20872562
[TBL] [Abstract][Full Text] [Related]
5. Surfactant protein D and KL-6 as serum biomarkers of interstitial lung disease in patients with scleroderma.
Hant FN; Ludwicka-Bradley A; Wang HJ; Li N; Elashoff R; Tashkin DP; Silver RM;
J Rheumatol; 2009 Apr; 36(4):773-80. PubMed ID: 19286849
[TBL] [Abstract][Full Text] [Related]
6. Comparative diagnostic efficacy of serum Krebs von den Lungen-6 and surfactant D for connective tissue disease-associated interstitial lung diseases: A meta-analysis.
Zhong D; Wu C; Bai J; Hu C; Xu D; Wang Q; Zeng X
Medicine (Baltimore); 2020 Apr; 99(16):e19695. PubMed ID: 32311947
[TBL] [Abstract][Full Text] [Related]
7. Marked increase in serum KL-6 and surfactant protein D levels during the first 4 weeks after treatment predicts poor prognosis in patients with active interstitial pneumonia associated with polymyositis/dermatomyositis.
Arai S; Kurasawa K; Maezawa R; Owada T; Okada H; Fukuda T
Mod Rheumatol; 2013 Sep; 23(5):872-83. PubMed ID: 22983659
[TBL] [Abstract][Full Text] [Related]
8. Pneumocyte biomarkers KL-6 and surfactant protein D reflect the distinct findings of high-resolution computed tomography in nonspecific interstitial pneumonia.
Ichiyasu H; Ichikado K; Yamashita A; Iyonaga K; Sakamoto O; Suga M; Kohrogi H
Respiration; 2012; 83(3):190-7. PubMed ID: 21555868
[TBL] [Abstract][Full Text] [Related]
9. Performance of Candidate Serum Biomarkers for Systemic Sclerosis-Associated Interstitial Lung Disease.
Elhai M; Hoffmann-Vold AM; Avouac J; Pezet S; Cauvet A; Leblond A; Fretheim H; Garen T; Kuwana M; Molberg Ø; Allanore Y
Arthritis Rheumatol; 2019 Jun; 71(6):972-982. PubMed ID: 30624031
[TBL] [Abstract][Full Text] [Related]
10. Surfactant protein-D is more useful than Krebs von den Lungen 6 as a marker for the early diagnosis of interstitial pneumonitis during pegylated interferon treatment for chronic hepatitis C.
Ishikawa T; Kubota T; Abe H; Hirose K; Nagashima A; Togashi T; Seki K; Honma T; Yoshida T; Kamimura T
Hepatogastroenterology; 2012 Oct; 59(119):2260-3. PubMed ID: 23435141
[TBL] [Abstract][Full Text] [Related]
11. Ionizing radiation-induced γ-H2AX activity in whole blood culture and the risk of lung cancer.
He Y; Gong Y; Lin J; Chang DW; Gu J; Roth JA; Wu X
Cancer Epidemiol Biomarkers Prev; 2013 Mar; 22(3):443-51. PubMed ID: 23300022
[TBL] [Abstract][Full Text] [Related]
12. Comprehensive investigation of novel serum markers of pulmonary fibrosis associated with systemic sclerosis and dermato/polymyositis.
Kumánovics G; Minier T; Radics J; Pálinkás L; Berki T; Czirják L
Clin Exp Rheumatol; 2008; 26(3):414-20. PubMed ID: 18578962
[TBL] [Abstract][Full Text] [Related]
13. [Clinical significance of serum KL-6 and SP-D for the diagnosis and treatment of interstitial lung disease in patients with diffuse connective tissue disorders].
Ogawa N; Shimoyama K; Kawabata H; Masaki Y; Wano Y; Sugai S
Ryumachi; 2003 Feb; 43(1):19-28. PubMed ID: 12692986
[TBL] [Abstract][Full Text] [Related]
14. Clinical importance of bronchoalveolar lavage fluid and blood cytokines, surfactant protein D, and Kerbs von Lungren 6 antigen in idiopathic pulmonary alveolar proteinosis.
Lin FC; Chen YC; Chang SC
Mayo Clin Proc; 2008 Dec; 83(12):1344-9. PubMed ID: 19046553
[TBL] [Abstract][Full Text] [Related]
15. Elevation of serum KL-6 glycoprotein or surfactant protein-D in adult T-cell leukemia with distinct pulmonary complications.
Osaka A; Yanagihara K; Yamada Y; Hasegawa H; Inokuchi N; Hayashi T; Komoda M; Nakamura S; Aoyama M; Sawada T; Kamihira S
Tohoku J Exp Med; 2009 Jun; 218(2):99-105. PubMed ID: 19478465
[TBL] [Abstract][Full Text] [Related]
16. The elevation of serum napsin A in idiopathic pulmonary fibrosis, compared with KL-6, surfactant protein-A and surfactant protein-D.
Samukawa T; Hamada T; Uto H; Yanagi M; Tsukuya G; Nosaki T; Maeda M; Hirano T; Tsubouchi H; Inoue H
BMC Pulm Med; 2012 Sep; 12():55. PubMed ID: 22963039
[TBL] [Abstract][Full Text] [Related]
17. Improving risk-stratification of rheumatoid arthritis patients for interstitial lung disease.
Avouac J; Cauvet A; Steelandt A; Shirai Y; Elhai M; Kuwana M; Distler O; Allanore Y
PLoS One; 2020; 15(5):e0232978. PubMed ID: 32384128
[TBL] [Abstract][Full Text] [Related]
18. Comparative Study of Circulating MMP-7, CCL18, KL-6, SP-A, and SP-D as Disease Markers of Idiopathic Pulmonary Fibrosis.
Hamai K; Iwamoto H; Ishikawa N; Horimasu Y; Masuda T; Miyamoto S; Nakashima T; Ohshimo S; Fujitaka K; Hamada H; Hattori N; Kohno N
Dis Markers; 2016; 2016():4759040. PubMed ID: 27293304
[TBL] [Abstract][Full Text] [Related]
19. [Assessment of serum markers KL-6 and SP-D for interstitial pneumonia associated with connective tissue diseases].
Suematsu E; Miyamura T; Shimada H; Nakao R; Yamamoto M
Ryumachi; 2003 Feb; 43(1):11-8. PubMed ID: 12692985
[TBL] [Abstract][Full Text] [Related]
20. Serum KL-6 and surfactant proteins A and D in pediatric interstitial lung disease.
Al-Salmi QA; Walter JN; Colasurdo GN; Sockrider MM; Smith EO; Takahashi H; Fan LL
Chest; 2005 Jan; 127(1):403-7. PubMed ID: 15654008
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]